J Fehr Selected Research

J Fehr Research Topics

Disease

7	Infections 01/2018 - 06/2004
3	Thrombosis (Thrombus) 10/2002 - 02/2001
2	Tuberculosis (Tuberculoses) 01/2020 - 10/2018
2	Hepatitis C 01/2020 - 11/2015
2	Coinfection 01/2016 - 11/2014
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2012 - 01/2009
1	Measles 06/2021
1	Syphilis 01/2020
1	Exanthema (Rash) 04/2017
1	Ocular Toxoplasmosis 04/2017
1	Drug-Related Side Effects and Adverse Reactions 04/2017
1	Vomiting 04/2017
1	Inflammation (Inflammations) 04/2017
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2017
1	Chronic Hepatitis C 11/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2015
1	Hypertension (High Blood Pressure) 09/2015
1	HIV Infections (HIV Infection) 09/2015
1	Liver Diseases (Liver Disease) 09/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2014
1	Fibrosis (Cirrhosis) 11/2014
1	Obesity 09/2014
1	Critical Illness (Critically Ill) 04/2013
1	Lung Neoplasms (Lung Cancer) 01/2012
1	Liver Failure 01/2009
1	Alcoholism (Alcohol Abuse) 01/2009
1	Surgical Wound Infection 12/2006
1	Eosinophilia 03/2006
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 03/2006
1	Pure Red-Cell Aplasia 11/2004
1	Rare Diseases (Rare Disease) 11/2004
1	Renal Insufficiency (Renal Failure) 11/2004
1	Venous Thromboembolism 10/2002
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2002
1	Persistent Polyclonal B-Cell Lymphocytosis 08/2001
1	Thrombophilia 03/2001
1	Epstein-Barr Virus Infections 03/2001
1	Splenomegaly 03/2001
1	Necrosis 05/2000

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 01/2020 - 01/2016
2	Antiviral Agents (Antivirals)IBA 01/2018 - 11/2015
2	EnzymesIBA 04/2017 - 01/2009
2	Protease Inhibitors (Protease Inhibitor)IBA 11/2015 - 11/2014
2	Heparin (Liquaemin)FDA LinkGeneric 03/2001 - 02/2001
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2020
1	Cocaine (Cocaine HCl)IBA 01/2020
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2020
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2020
1	Hepatitis C AntibodiesIBA 01/2018
1	CreatinineIBA 04/2017
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2017
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2017
1	insulin receptor-related receptor (IRR)IBA 09/2015
1	Ribavirin (Virazole)FDA LinkGeneric 11/2014
1	Silybin (Lagosa)IBA 11/2014
1	Daptomycin FDA Link 04/2013
1	Lamivudine (Epivir)FDA Link 01/2009
1	Adenosine Monophosphate (AMP)IBA 12/2006
1	Methylprednisolone FDA LinkGeneric 03/2006
1	Mebendazole (Anti-Worm)FDA Link 03/2006
1	AntibodiesIBA 11/2004
1	Erythropoietin FDA Link 11/2004
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2004
1	Plasminogen Activator Inhibitor 1IBA 10/2002
1	Proteins (Proteins, Gene)FDA Link 10/2002
1	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2002
1	Factor VIII (Coagulation Factor VIII)IBA 10/2002
1	ThrombomodulinIBA 10/2002
1	von Willebrand FactorIBA 10/2002
1	Immunoglobulin D (IgD)IBA 08/2001
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 03/2001
1	Immunoglobulin M (IgM)IBA 03/2001
1	Antithrombin IIIIBA 02/2001
1	Thrombin FDA Link 02/2001
1	fibrin fragment D (D-dimer)IBA 02/2001
1	Pancreatic Elastase (Elastase)IBA 05/2000
1	InterleukinsIBA 05/2000
1	Muramidase (Lysozyme)IBA 05/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2000
1	Interleukin-10 (Interleukin 10)IBA 05/2000
1	Ferritins (Ferritin)IBA 05/2000
1	InterferonsIBA 05/2000
1	Interleukin-8 (Interleukin 8)IBA 05/2000
1	NeopterinIBA 05/2000

Therapy/Procedure

7	Therapeutics 04/2017 - 02/2001
2	Art Therapy 09/2014 - 01/2009
1	Contraindications 06/2021
1	Continuous Renal Replacement Therapy 04/2013